<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 76-year-old man with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> was referred to us for radioembolization of the liver </plain></SENT>
<SENT sid="1" pm="."><plain>Angiography with 99mTc-<z:chebi fb="8" ids="35738">MAA</z:chebi> SPECT/CT was performed 8 weeks after the discontinuation of bevacizumab </plain></SENT>
<SENT sid="2" pm="."><plain>99mTc-<z:chebi fb="8" ids="35738">MAA</z:chebi> SPECT/CT showed a diffused intrahepatic tracer distribution with no focally accentuated accumulation in the tumorous region </plain></SENT>
<SENT sid="3" pm="."><plain>The test was repeated 6 weeks later and Tc-<z:chebi fb="8" ids="35738">MAA</z:chebi> SPECT/CT showed this time a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> accentuated tracer accumulation in the liver </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequently, the patient was treated with resin microspheres </plain></SENT>
<SENT sid="5" pm="."><plain>Tc-<z:chebi fb="8" ids="35738">MAA</z:chebi> SPECT/CT allows a better evaluation of intrahepatic tracer accumulation of Tc-<z:chebi fb="8" ids="35738">MAA</z:chebi> and facilitates the determination of the most appropriate treatment time </plain></SENT>
</text></document>